立即登录 | 免费注册
全部学科 | 内科学 | 心血管病学 | 内分泌学与糖尿病 | 神经病学 | 消化病学 | 呼吸病学 | 肿瘤学 | 妇产科学 | 骨科学
疾病中心: 高血压 | 冠心病 | 心力衰竭 | 心律失常 | 脂肪性肝病 | 糖尿病 | 卒中 | 慢性阻塞性肺病 | 子宫内膜异位症 | 乳腺癌 | 肺癌 | 结直肠癌 | 器官移植
Loading
当前位置:期刊中心 > 中国作者重要发表 > 文摘导读

中国及西方人群中前列腺癌患者显著的基因组改变提示前列腺癌的形成另有途径

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis
Mao X, Yu Y, Boyd L K, Ren G, Lin D, Chaplin T, Kudahetti S C, Stankiewicz E, Xue L, Beltran L, Gupta M, Oliver R T D, Lemoine N R, Berney D M, Young B D, Lu Y -J   |   2010/7/29 15:04:00 
Cancer Research, 2010   |   Volume 70, Issue 13  |   打印| 推荐给好友
上一篇: 雄激素阻断治疗后酪氨酸激酶Etk/BMX代偿性上调可促进前列腺癌细胞的去势抵抗性生长
下一篇: 破解neurexin和neuroligin剪接异构体编码的结构性方法

Prostate cancer is significantly more common in Western men than in Asian men, but the basis for this difference remains unknown. Because genomic studies of Asian prostate cancer are very limited, we used a genome-wide approach to reveal the genomic alterations in Chinese prostate cancers. We found a significant reduction in the frequency of certain somatic genomic changes that are commonly found in Western prostate cancers, including the 21q22.2-22.3 deletion, which involves the TMPRSS2:ERG fusion gene, and 10q deletion, which causes PTEN inactivation. Array results were confirmed by PCR-based molecular copy-number counting in selected samples. The different frequencies of these genomic changes were further evaluated by fluorescent in situ hybridization and immunohistochemistry analyses of tissue microarray samples. These alterations might be key genetic changes underlying the regional/ethnic difference in clinical incidence and might be induced by specific environmental and/or genetic risk factors that Western men are exposed to. Our findings suggest that tumors arise in Western and Chinese populations by alternative pathogenetic mechanisms. ©2010 AACR.

Correspondence Address: Lu, Y.-J.; Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; email:y.j.lu@qmul.ac.uk 
关键词:

请登录后发表评论,点击此处登录。

慢性心衰诊治:规范中求突破
黄峻
2012-2-1
南京医科大学第一附属医院
房颤治疗:手段渐趋丰富 新型治疗药物不断涌现 非药物治疗备受关注
马长生
2012-2-1
首都医科大学附属北京安贞医院
注重老年人群特征 优化管理

刘梅林
2012-2-1
北京大学第一医院老年内科

 

相关文章